Key statistics
On Tuesday, Immutep Ltd (IMM:ASX) closed at 0.375, -20.21% below its 52-week high of 0.47, set on Jan 14, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.37 |
|---|---|
| High | 0.38 |
| Low | 0.37 |
| Bid | 0.375 |
| Offer | 0.39 |
| Previous close | 0.37 |
| Average volume | 2.92m |
|---|---|
| Shares outstanding | 1.47bn |
| Free float | 1.21bn |
| P/E (TTM) | -- |
| Market cap | 545.28m AUD |
| EPS (TTM) | -0.0422 AUD |
Data delayed at least 20 minutes, as of Feb 10 2026 05:10 GMT.
More ▼
Announcements
- Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
- Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
- Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
